High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events

BACKGROUND: Brachytherapy (BT) is a vital component of the curative treatment of locally advanced cervical cancer. The American Brachytherapy Society has published guidelines for high dose rate (HDR) BT with recommended dose limits. However, recent reports suggest lower doses may be needed to avoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Romano, Kara D., Hill, Colin, Trifiletti, Daniel M., Peach, M. Sean, Horton, Bethany J., Shah, Neil, Campbell, Dylan, Libby, Bruce, Showalter, Timothy N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048838/
https://www.ncbi.nlm.nih.gov/pubmed/30012164
http://dx.doi.org/10.1186/s13014-018-1074-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048838/
https://www.ncbi.nlm.nih.gov/pubmed/30012164
http://dx.doi.org/10.1186/s13014-018-1074-2

Ejemplares similares